This table presents recent patent oppositions filed by Alnylam Pharmaceuticals Inc. against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3222724Further Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICS GMBHOct 31, 2018
EP2258847Futher Novel Forms Of Interfering Rna MoleculesSILENCE THERAPEUTICS AGOct 19, 2017